Registered Nurse in Cochrane, WI Accepting Medicare
4 Registered Nurse nurses found. Showing 1 - 4
 Kimberlee Kirste, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 107 Wisconsin Ave, Cochrane, WI 54622 Phone: 715-497-5222 |
Jamie Lee Pronschinske, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 501 S Main St, Cochrane, WI 54622 Phone: 507-990-0960 |
Jessica Kathleen Mattson, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 107 Wisconsin Ave, Cochrane, WI 54622 Phone: 507-730-1453 |
Shelby Lynn Spence, RN Registered Nurse - Home Health Medicare: Not Enrolled in Medicare Practice Location: 107 Wisconsin Ave, Cochrane, WI 54622 Phone: 715-497-5222 |
News Archive
Sanford-Burnham scientists identify how enzyme PKCzeta suppresses prostate tumor formation
Scientists at Sanford-Burnham Medical Research Institute have identified how an enzyme called PKCĪ¶ suppresses prostate tumor formation. The finding, which also describes a molecular chain of events that controls cell growth and metastasis, could lead to novel ways to control disease progression.
Techulon receives U.S. patent protection for Glycofect Discovery and Therapeutic Delivery Platform
Techulon, Inc. announced today that its Glycofect Discovery and Therapeutic Delivery Platform has been awarded United States patent protection. The patented invention provides a new class of non-viral transfection vectors based on synthetic carbohydrate containing polyamides that can be used for both in vivo and in vitro applications.
GlobalNet Services awarded $14M contract to support FDA Unified Registration and Listing System
GlobalNet Services, Inc., a premier information technology provider for businesses and the Federal government, today announced that it had been awarded a $14 million contract to support the U.S. Food and Drug Administration's (FDA) Unified Registration and Listing System (FURLS). This five-year contract, which includes one base year and four option years, supports federal initiatives that require all facilities, which manufacture, process or hold FDA-regulated products to be registered with the Agency.
Clivatuzumab tetraxetan shows promising results in patients with metastatic pancreatic cancer
Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that its proprietary antibody, clivatuzumab tetraxetan, labeled with yttrium-90 plus low-dose gemcitabine continues to produce promising efficacy results in patients with previously untreated, inoperable, locally advanced or metastatic pancreatic cancer.
Social norms interventions to reduce alcohol misuse in students
Giving students personalised feedback on their drinking behaviour and how it compares to social norms might help to reduce alcohol misuse, according to a Cochrane Systematic Review.
› Verified 8 days ago